Evaluation of phenotypic screening methods for detecting plasmid-mediated AmpC beta-lactamases-producing isolates of Escherichia coli and Klebsiella pneumoniae.

[1]  Y. Chong,et al.  Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins , 1989, Infection.

[2]  V. Lorian.  Antibiotics in laboratory medicine , 2005 .

[3]  D. Yong,et al.  Emergence of Multidrug-Resistant Salmonella enterica Serovar Typhi in Korea , 2004, Antimicrobial Agents and Chemotherapy.

[4]  D. Church,et al.  New Method for Laboratory Detection of AmpC β-Lactamases in Escherichia coli and Klebsiella pneumoniae , 2004, Journal of Clinical Microbiology.

[5]  S. Singhal,et al.  Phenotypic detection of extended-spectrum and AmpC beta-lactamases by a new spot-inoculation method and modified three-dimensional extract test: comparison with the conventional three-dimensional extract test. , 2004, The Journal of antimicrobial chemotherapy.

[6]  G. Jacoby,et al.  Epidemiology of Conjugative Plasmid-Mediated AmpC β-Lactamases in the United States , 2004, Antimicrobial Agents and Chemotherapy.

[7]  D. Yong,et al.  Evaluation of the Hodge Test and the Imipenem-EDTA Double-Disk Synergy Test for Differentiating Metallo-β-Lactamase-Producing Isolates of Pseudomonas spp. and Acinetobacter spp , 2003, Journal of Clinical Microbiology.

[8]  D. Church,et al.  Modification of the Double-Disk Test for Detection of Enterobacteriaceae Producing Extended-Spectrum and AmpC β-Lactamases , 2003, Journal of Clinical Microbiology.

[9]  N. Hanson.  AmpC β-lactamases: what do we need to know for the future? , 2003 .

[10]  Ronald N. Jones,et al.  Antimicrobial activity of broad-spectrum agents tested against Gram-negative bacilli resistant to ceftazidime: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). , 2002, Diagnostic microbiology and infectious disease.

[11]  D. Yong,et al.  Further modification of the Hodge test to screen AmpC beta-lactamase (CMY-1)-producing strains of Escherichia coli and Klebsiella pneumoniae. , 2002, Journal of microbiological methods.

[12]  J. Wu,et al.  Emergence of Klebsiella pneumoniae Isolates Producing Inducible DHA-1 β-Lactamase in a University Hospital in Taiwan , 2002, Journal of Clinical Microbiology.

[13]  N. Hanson,et al.  Detection of Plasmid-Mediated AmpC β-Lactamase Genes in Clinical Isolates by Using Multiplex PCR , 2002, Journal of Clinical Microbiology.

[14]  George A. Jacoby,et al.  Plasmid-Determined AmpC-Type β-Lactamases , 2002, Antimicrobial Agents and Chemotherapy.

[15]  R. Cantón,et al.  Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  P. Coudron,et al.  Occurrence and Detection of AmpC Beta-Lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis Isolates at a Veterans Medical Center , 2000, Journal of Clinical Microbiology.

[17]  J. J. Farmer.  Enterobacteriaceae : introduction and identification , 1995 .

[18]  G. Papanicolaou,et al.  Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae , 1990, Antimicrobial Agents and Chemotherapy.

[19]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .